nodes	percent_of_prediction	percent_of_DWPC	metapath
Azelastine—CYP2A6—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.062	0.062	CbGpPWpGaD
Azelastine—CYP2A6—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0543	0.0543	CbGpPWpGaD
Azelastine—CYP2E1—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.049	0.049	CbGpPWpGaD
Azelastine—CYP1A1—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.0462	0.0462	CbGpPWpGaD
Azelastine—CYP2E1—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0429	0.0429	CbGpPWpGaD
Azelastine—CYP1A1—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0405	0.0405	CbGpPWpGaD
Azelastine—CYP2D6—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.0347	0.0347	CbGpPWpGaD
Azelastine—CYP2D6—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0305	0.0305	CbGpPWpGaD
Azelastine—CYP1A2—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.0294	0.0294	CbGpPWpGaD
Azelastine—CYP1A2—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0258	0.0258	CbGpPWpGaD
Azelastine—CYP3A4—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.0227	0.0227	CbGpPWpGaD
Azelastine—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0199	0.0199	CbGpPWpGaD
Azelastine—CYP2A6—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0174	0.0174	CbGpPWpGaD
Azelastine—CYP2A6—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.0153	0.0153	CbGpPWpGaD
Azelastine—CYP2B6—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0141	0.0141	CbGpPWpGaD
Azelastine—CYP2E1—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0138	0.0138	CbGpPWpGaD
Azelastine—CYP3A5—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0138	0.0138	CbGpPWpGaD
Azelastine—CYP1A1—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.013	0.013	CbGpPWpGaD
Azelastine—CYP2B6—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.0123	0.0123	CbGpPWpGaD
Azelastine—CYP2E1—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.0121	0.0121	CbGpPWpGaD
Azelastine—CYP3A5—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.0121	0.0121	CbGpPWpGaD
Azelastine—CYP2C8—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0119	0.0119	CbGpPWpGaD
Azelastine—CYP1A1—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.0114	0.0114	CbGpPWpGaD
Azelastine—CYP2C19—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0106	0.0106	CbGpPWpGaD
Azelastine—CYP2A6—NRF2 pathway—ADH7—pharynx cancer	0.0106	0.0106	CbGpPWpGaD
Azelastine—CYP2C8—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.0104	0.0104	CbGpPWpGaD
Azelastine—CYP2A6—Biological oxidations—CNDP2—pharynx cancer	0.0102	0.0102	CbGpPWpGaD
Azelastine—CYP2D6—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00978	0.00978	CbGpPWpGaD
Azelastine—CYP2C9—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0097	0.0097	CbGpPWpGaD
Azelastine—CYP2C19—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00933	0.00933	CbGpPWpGaD
Azelastine—CYP2A6—Biological oxidations—ADH7—pharynx cancer	0.00927	0.00927	CbGpPWpGaD
Azelastine—CYP2D6—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00858	0.00858	CbGpPWpGaD
Azelastine—CYP2C9—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.0085	0.0085	CbGpPWpGaD
Azelastine—CYP1A2—Phase II conjugation—CNDP2—pharynx cancer	0.00832	0.00832	CbGpPWpGaD
Azelastine—CYP1A2—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00829	0.00829	CbGpPWpGaD
Azelastine—CYP2B6—Biological oxidations—CNDP2—pharynx cancer	0.00827	0.00827	CbGpPWpGaD
Azelastine—CYP2A6—Biological oxidations—ADH1B—pharynx cancer	0.00813	0.00813	CbGpPWpGaD
Azelastine—CYP2E1—Biological oxidations—CNDP2—pharynx cancer	0.0081	0.0081	CbGpPWpGaD
Azelastine—CYP3A5—Biological oxidations—CNDP2—pharynx cancer	0.00808	0.00808	CbGpPWpGaD
Azelastine—CYP1A1—Biological oxidations—CNDP2—pharynx cancer	0.00763	0.00763	CbGpPWpGaD
Azelastine—CYP2B6—Biological oxidations—ADH7—pharynx cancer	0.00748	0.00748	CbGpPWpGaD
Azelastine—CYP2E1—Biological oxidations—ADH7—pharynx cancer	0.00732	0.00732	CbGpPWpGaD
Azelastine—CYP3A5—Biological oxidations—ADH7—pharynx cancer	0.00731	0.00731	CbGpPWpGaD
Azelastine—CYP1A2—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00727	0.00727	CbGpPWpGaD
Azelastine—CYP2C8—Biological oxidations—CNDP2—pharynx cancer	0.007	0.007	CbGpPWpGaD
Azelastine—CYP1A1—Biological oxidations—ADH7—pharynx cancer	0.0069	0.0069	CbGpPWpGaD
Azelastine—CYP2B6—Biological oxidations—ADH1B—pharynx cancer	0.00656	0.00656	CbGpPWpGaD
Azelastine—CYP2E1—Biological oxidations—ADH1B—pharynx cancer	0.00642	0.00642	CbGpPWpGaD
Azelastine—CYP3A5—Biological oxidations—ADH1B—pharynx cancer	0.00641	0.00641	CbGpPWpGaD
Azelastine—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0064	0.0064	CbGpPWpGaD
Azelastine—CYP2C8—Biological oxidations—ADH7—pharynx cancer	0.00633	0.00633	CbGpPWpGaD
Azelastine—CYP2C19—Biological oxidations—CNDP2—pharynx cancer	0.00625	0.00625	CbGpPWpGaD
Azelastine—CYP1A1—Biological oxidations—ADH1B—pharynx cancer	0.00605	0.00605	CbGpPWpGaD
Azelastine—CYP2D6—Biological oxidations—CNDP2—pharynx cancer	0.00575	0.00575	CbGpPWpGaD
Azelastine—CYP2C9—Biological oxidations—CNDP2—pharynx cancer	0.0057	0.0057	CbGpPWpGaD
Azelastine—CYP2C19—Biological oxidations—ADH7—pharynx cancer	0.00565	0.00565	CbGpPWpGaD
Azelastine—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00561	0.00561	CbGpPWpGaD
Azelastine—CYP2C8—Biological oxidations—ADH1B—pharynx cancer	0.00555	0.00555	CbGpPWpGaD
Azelastine—CYP2D6—Biological oxidations—ADH7—pharynx cancer	0.0052	0.0052	CbGpPWpGaD
Azelastine—CYP2C9—Biological oxidations—ADH7—pharynx cancer	0.00515	0.00515	CbGpPWpGaD
Azelastine—CYP2C19—Biological oxidations—ADH1B—pharynx cancer	0.00495	0.00495	CbGpPWpGaD
Azelastine—CYP1A2—Biological oxidations—CNDP2—pharynx cancer	0.00487	0.00487	CbGpPWpGaD
Azelastine—CYP2D6—Biological oxidations—ADH1B—pharynx cancer	0.00456	0.00456	CbGpPWpGaD
Azelastine—CYP2C9—Biological oxidations—ADH1B—pharynx cancer	0.00452	0.00452	CbGpPWpGaD
Azelastine—CYP1A2—Biological oxidations—ADH7—pharynx cancer	0.0044	0.0044	CbGpPWpGaD
Azelastine—CYP2A6—Fluoropyrimidine Activity—TP53—pharynx cancer	0.00436	0.00436	CbGpPWpGaD
Azelastine—CYP1A2—Biological oxidations—ADH1B—pharynx cancer	0.00386	0.00386	CbGpPWpGaD
Azelastine—CYP3A4—Biological oxidations—CNDP2—pharynx cancer	0.00376	0.00376	CbGpPWpGaD
Azelastine—CYP3A4—Biological oxidations—ADH7—pharynx cancer	0.0034	0.0034	CbGpPWpGaD
Azelastine—ADRA1B—LPA receptor mediated events—EGFR—pharynx cancer	0.00319	0.00319	CbGpPWpGaD
Azelastine—CYP3A4—Biological oxidations—ADH1B—pharynx cancer	0.00298	0.00298	CbGpPWpGaD
Azelastine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—pharynx cancer	0.00297	0.00297	CbGpPWpGaD
Azelastine—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—pharynx cancer	0.00297	0.00297	CbGpPWpGaD
Azelastine—ADRA1B—AMPK Signaling—TP53—pharynx cancer	0.00252	0.00252	CbGpPWpGaD
Azelastine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—pharynx cancer	0.00189	0.00189	CbGpPWpGaD
Azelastine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—pharynx cancer	0.00189	0.00189	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—CNDP2—pharynx cancer	0.00175	0.00175	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—ADH7—pharynx cancer	0.00158	0.00158	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—CNDP2—pharynx cancer	0.00141	0.00141	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—ADH1B—pharynx cancer	0.00139	0.00139	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—CNDP2—pharynx cancer	0.00138	0.00138	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—CNDP2—pharynx cancer	0.00138	0.00138	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—B4GALT5—pharynx cancer	0.00133	0.00133	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—CNDP2—pharynx cancer	0.00131	0.00131	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—ADH7—pharynx cancer	0.00128	0.00128	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—ADH7—pharynx cancer	0.00125	0.00125	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—ADH7—pharynx cancer	0.00125	0.00125	CbGpPWpGaD
Azelastine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pharynx cancer	0.00121	0.00121	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—CNDP2—pharynx cancer	0.0012	0.0012	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—ADH7—pharynx cancer	0.00118	0.00118	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—ADH1B—pharynx cancer	0.00112	0.00112	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—ADH1B—pharynx cancer	0.0011	0.0011	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—ADH1B—pharynx cancer	0.0011	0.0011	CbGpPWpGaD
Azelastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pharynx cancer	0.00109	0.00109	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—ADH7—pharynx cancer	0.00108	0.00108	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—B4GALT5—pharynx cancer	0.00107	0.00107	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—CNDP2—pharynx cancer	0.00107	0.00107	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—B4GALT5—pharynx cancer	0.00105	0.00105	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—B4GALT5—pharynx cancer	0.00105	0.00105	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—CNDP2—pharynx cancer	0.00104	0.00104	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—ADH1B—pharynx cancer	0.00104	0.00104	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—B4GALT5—pharynx cancer	0.00099	0.00099	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—CNDP2—pharynx cancer	0.000983	0.000983	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—CNDP2—pharynx cancer	0.000974	0.000974	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	0.000967	0.000967	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—ADH7—pharynx cancer	0.000966	0.000966	CbGpPWpGaD
Azelastine—HRH3—Signaling by GPCR—EGFR—pharynx cancer	0.000959	0.000959	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—ADH1B—pharynx cancer	0.000949	0.000949	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—ADH7—pharynx cancer	0.000943	0.000943	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—B4GALT5—pharynx cancer	0.000907	0.000907	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—ADH7—pharynx cancer	0.000889	0.000889	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—ADH7—pharynx cancer	0.000881	0.000881	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—ADH1B—pharynx cancer	0.000847	0.000847	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—CNDP2—pharynx cancer	0.000833	0.000833	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—ADH1B—pharynx cancer	0.000827	0.000827	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—B4GALT5—pharynx cancer	0.00081	0.00081	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—B4GALT5—pharynx cancer	0.00079	0.00079	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—ADH1B—pharynx cancer	0.000779	0.000779	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—ADH1B—pharynx cancer	0.000773	0.000773	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.000759	0.000759	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—ADH7—pharynx cancer	0.000753	0.000753	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—B4GALT5—pharynx cancer	0.000745	0.000745	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—B4GALT5—pharynx cancer	0.000738	0.000738	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—CCND1—pharynx cancer	0.000722	0.000722	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—ADH1B—pharynx cancer	0.00066	0.00066	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CNDP2—pharynx cancer	0.000643	0.000643	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.000637	0.000637	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—B4GALT5—pharynx cancer	0.000631	0.000631	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—ADH7—pharynx cancer	0.000581	0.000581	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—EGFR—pharynx cancer	0.000566	0.000566	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—ADH1B—pharynx cancer	0.00051	0.00051	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—B4GALT5—pharynx cancer	0.000487	0.000487	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—TP53—pharynx cancer	0.000476	0.000476	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—EGFR—pharynx cancer	0.00035	0.00035	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—EGFR—pharynx cancer	0.000317	0.000317	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CCND1—pharynx cancer	0.000263	0.000263	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CCND1—pharynx cancer	0.000238	0.000238	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—EGFR—pharynx cancer	0.000207	0.000207	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—EGFR—pharynx cancer	0.000187	0.000187	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—TP53—pharynx cancer	0.000174	0.000174	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—TP53—pharynx cancer	0.000157	0.000157	CbGpPWpGaD
